• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载体物理性质对干粉吸入器性能的影响。

Influence of physical properties of carrier on the performance of dry powder inhalers.

作者信息

Peng Tingting, Lin Shiqi, Niu Boyi, Wang Xinyi, Huang Ying, Zhang Xuejuan, Li Ge, Pan Xin, Wu Chuanbin

机构信息

School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.

Guangzhou Neworld Pharm. Co. Ltd., Guangzhou 51006, China.

出版信息

Acta Pharm Sin B. 2016 Jul;6(4):308-18. doi: 10.1016/j.apsb.2016.03.011. Epub 2016 May 4.

DOI:10.1016/j.apsb.2016.03.011
PMID:27471671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4951591/
Abstract

Dry powder inhalers (DPIs) offer distinct advantages as a means of pulmonary drug delivery and have attracted much attention in the field of pharmaceutical science. DPIs commonly contain micronized drug particles which, because of their cohesiveness and strong propensity to aggregate, have poor aerosolization performance. Thus carriers with a larger particle size are added to address this problem. However, the performance of DPIs is profoundly influenced by the physical properties of the carrier, particularly their particle size, morphology/shape and surface roughness. Because these factors are interdependent, it is difficult to completely understand how they individually influence DPI performance. The purpose of this review is to summarize and illuminate how these factors affect drug-carrier interaction and influence the performance of DPIs.

摘要

干粉吸入器(DPIs)作为一种肺部给药方式具有显著优势,在制药科学领域备受关注。DPIs通常含有微粉化药物颗粒,由于其粘性和强烈的聚集倾向,雾化性能较差。因此,添加粒径较大的载体来解决这个问题。然而,DPIs的性能受到载体物理性质的深刻影响,特别是其粒径、形态/形状和表面粗糙度。由于这些因素相互依存,很难完全理解它们如何分别影响DPIs的性能。本综述的目的是总结并阐明这些因素如何影响药物-载体相互作用并影响DPIs的性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/fd1f19a89846/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/b145df646a5a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/cec5ab57ce85/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/134a96b0b6da/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/ee844b8ee478/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/b14548e71ed4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/062d41c32264/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/8a3ed31afb58/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/fd1f19a89846/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/b145df646a5a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/cec5ab57ce85/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/134a96b0b6da/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/ee844b8ee478/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/b14548e71ed4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/062d41c32264/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/8a3ed31afb58/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/4951591/fd1f19a89846/gr7.jpg

相似文献

1
Influence of physical properties of carrier on the performance of dry powder inhalers.载体物理性质对干粉吸入器性能的影响。
Acta Pharm Sin B. 2016 Jul;6(4):308-18. doi: 10.1016/j.apsb.2016.03.011. Epub 2016 May 4.
2
A real-time and modular approach for quick detection and mechanism exploration of DPIs with different carrier particle sizes.一种用于快速检测不同载体颗粒尺寸的干粉吸入剂并探索其作用机制的实时模块化方法。
Acta Pharm Sin B. 2022 Jan;12(1):437-450. doi: 10.1016/j.apsb.2021.06.011. Epub 2021 Jun 21.
3
Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.阐明细乳糖比例对吸入用干粉流变性能和空气动力学行为的影响。
AAPS J. 2021 Apr 15;23(3):55. doi: 10.1208/s12248-021-00582-0.
4
Elucidation of lactose fine size and drug shape on rheological properties and aerodynamic behavior of dry powders for inhalation.阐明乳糖的细微颗粒大小和药物形状对吸入干粉的流变性能和空气动力学行为的影响。
Eur J Pharm Biopharm. 2022 Oct;179:47-57. doi: 10.1016/j.ejpb.2022.08.007. Epub 2022 Aug 25.
5
Novel approach for real-time monitoring of carrier-based DPIs delivery process pulmonary route based on modular modified Sympatec HELOS.基于模块化改进的Sympatec HELOS对基于载体的干粉吸入器经肺途径给药过程进行实时监测的新方法。
Acta Pharm Sin B. 2020 Jul;10(7):1331-1346. doi: 10.1016/j.apsb.2020.02.013. Epub 2020 Mar 4.
6
Characterizing the Surface Roughness Length Scales of Lactose Carrier Particles in Dry Powder Inhalers.表征干粉吸入器中乳糖载体颗粒的表面粗糙度长度尺度。
Mol Pharm. 2018 Apr 2;15(4):1635-1642. doi: 10.1021/acs.molpharmaceut.8b00007. Epub 2018 Mar 6.
7
Surface Modification of lactose carrier particles using a fluid bed coater to improve fine particle fraction for dry powder inhalers.使用流化床包衣机对乳糖载体颗粒进行表面改性,以改善干粉吸入剂的细颗粒分数。
Pharm Dev Technol. 2023 Feb;28(2):164-175. doi: 10.1080/10837450.2023.2171434. Epub 2023 Jan 26.
8
Improving Dry Powder Inhaler Performance by Surface Roughening of Lactose Carrier Particles.通过乳糖载体颗粒表面粗糙化提高干粉吸入器性能。
Pharm Res. 2016 Aug;33(8):1923-35. doi: 10.1007/s11095-016-1928-y. Epub 2016 Apr 18.
9
Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.以具有定制表面形态的喷雾干燥甘露醇为载体和硫酸沙丁胺醇的干粉吸入器性能。
Int J Pharm. 2017 May 30;524(1-2):351-363. doi: 10.1016/j.ijpharm.2017.03.055. Epub 2017 Mar 24.
10
Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.CFD 结合拉格朗日粒子追踪在干粉吸入器中应用的潜力和限制。
Eur J Pharm Sci. 2019 Feb 1;128:299-324. doi: 10.1016/j.ejps.2018.12.008. Epub 2018 Dec 14.

引用本文的文献

1
Charged Particle Dynamics in Dry Powder Inhalers.干粉吸入器中的带电粒子动力学
Mol Pharm. 2025 Sep 1;22(9):5485-5492. doi: 10.1021/acs.molpharmaceut.5c00485. Epub 2025 Aug 13.
2
[Advances in inhalable nano-formulations].[可吸入纳米制剂的进展]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 Jul 3;54(4):511-521. doi: 10.3724/zdxbyxb-2024-0650.
3
Fabrication and evaluation of solidified nanoemulsion designs for systemic delivery of atorvastatin through the lung.用于阿托伐他汀经肺全身递送的固化纳米乳剂设计的制备与评价

本文引用的文献

1
Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.含L-亮氨酸的可吸入喷雾冷冻干燥粉末,其输送的颗粒与吸气流动模式和吸入装置无关。
Pharm Res. 2016 Apr;33(4):922-31. doi: 10.1007/s11095-015-1838-4. Epub 2015 Dec 7.
2
Three-dimensional DEM-CFD analysis of air-flow-induced detachment of API particles from carrier particles in dry powder inhalers.干粉吸入器中气流导致活性药物成分颗粒从载体颗粒上脱离的三维离散单元法-计算流体动力学分析
Acta Pharm Sin B. 2014 Feb;4(1):52-9. doi: 10.1016/j.apsb.2013.11.003. Epub 2014 Jan 1.
3
Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance.
Sci Rep. 2025 Jul 1;15(1):20884. doi: 10.1038/s41598-025-05646-1.
4
Assessment of Innovative Dry Powders for Inhalation of a Synergistic Combination Against in Infected Macrophages and Mice.评估用于吸入的创新型干粉剂,其为针对受感染巨噬细胞和小鼠的协同组合。
Pharmaceutics. 2025 May 27;17(6):705. doi: 10.3390/pharmaceutics17060705.
5
Preparation and Study of Erythromycin Dry Powder Inhaler Based on Ternary Complex Structure.基于三元复合结构的红霉素干粉吸入剂的制备与研究
AAPS PharmSciTech. 2025 May 30;26(5):151. doi: 10.1208/s12249-025-03140-5.
6
Particle surface coating for dry powder inhaler formulations.用于干粉吸入剂制剂的颗粒表面包衣
Expert Opin Drug Deliv. 2025 May;22(5):711-727. doi: 10.1080/17425247.2025.2482052. Epub 2025 Mar 26.
7
Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections.用于囊性纤维化相关感染吸入治疗的妥布霉素与透明质酸和透明质酸钠的聚电解质复合干粉制剂
Antibiotics (Basel). 2025 Feb 8;14(2):169. doi: 10.3390/antibiotics14020169.
8
Evaporation Kinetics and Final Particle Morphology of Multicomponent Salt Solution Droplets.多组分盐溶液微滴的蒸发动力学及最终颗粒形态
J Phys Chem A. 2025 Jan 23;129(3):762-773. doi: 10.1021/acs.jpca.4c07439. Epub 2025 Jan 11.
9
Formulation and characterization of inhalable dasatinib-nanoemulsion as a treatment potential against A549 and Calu-3 lung cancer cells.可吸入性达沙替尼纳米乳剂的制备及其对A549和Calu-3肺癌细胞治疗潜力的表征
Int J Health Sci (Qassim). 2025 Jan-Feb;19(1):4-14.
10
Scale-Up and Postapproval Changes in Orally Inhaled Drug Products: Scientific and Regulatory Considerations.吸入式口服药品的扩大生产及批准后变更:科学与监管考量
J Aerosol Med Pulm Drug Deliv. 2025 Apr;38(2):39-63. doi: 10.1089/jamp.2024.0036. Epub 2024 Dec 9.
基于载体的干粉吸入剂:载体改性对胶囊填充工艺性能和体外空气动力学性能的影响。
Int J Pharm. 2015 Aug 1;491(1-2):231-42. doi: 10.1016/j.ijpharm.2015.06.044. Epub 2015 Jun 29.
4
Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs.妥布霉素吸入粉雾剂的物理特性:I. 用于肺部给药的稳定工程颗粒制剂的合理设计。
Mol Pharm. 2015 Aug 3;12(8):2582-93. doi: 10.1021/acs.molpharmaceut.5b00147. Epub 2015 Jun 30.
5
Influence of surface characteristics of modified glass beads as model carriers in dry powder inhalers (DPIs) on the aerosolization performance.作为干粉吸入器(DPI)中模型载体的改性玻璃珠表面特性对雾化性能的影响。
Drug Dev Ind Pharm. 2015;41(10):1710-7. doi: 10.3109/03639045.2014.997246. Epub 2015 Jan 30.
6
Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.用于改善丙酸氟替卡松干粉吸入器性能的表面改性乳糖颗粒的制备与评价
J Aerosol Med Pulm Drug Deliv. 2015 Aug;28(4):254-67. doi: 10.1089/jamp.2014.1146. Epub 2014 Dec 17.
7
Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.干粉吸入器:一种有前景的替代载体——冻干甘露醇的几个粒径级分的物理化学性质和气溶胶化特性
Eur J Pharm Sci. 2015 Feb 20;68:56-67. doi: 10.1016/j.ejps.2014.12.005. Epub 2014 Dec 9.
8
In vitro dry powder inhaler formulation performance considerations.干粉吸入器制剂的体外性能考量。
J Control Release. 2015 Feb 10;199:45-52. doi: 10.1016/j.jconrel.2014.11.035. Epub 2014 Dec 9.
9
A novel aerosol generator for homogenous distribution of powder over the lungs after pulmonary administration to small laboratory animals.一种新型气溶胶发生器,用于在对小型实验动物进行肺部给药后,使粉末在肺部均匀分布。
Eur J Pharm Biopharm. 2014 Nov;88(3):1056-63. doi: 10.1016/j.ejpb.2014.10.011.
10
Pulmonary drug delivery by powder aerosols.粉末气溶胶肺部递药。
J Control Release. 2014 Nov 10;193:228-40. doi: 10.1016/j.jconrel.2014.04.055. Epub 2014 May 9.